Description

C(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm CAS NO 1647119-71-8 is a synthetic peptide compound of significant interest in advanced pharmaceutical research and development. This molecule is primarily valued for its potential as a key intermediate or active pharmaceutical ingredient (API) in the creation of novel therapeutic agents. It is specifically targeted by research institutions and pharmaceutical companies engaged in drug discovery programs, particularly those focusing on metabolic disorders, oncology, and targeted peptide therapies. The compound's complex structure allows for precise biological interactions, making it a critical component for high-value biopharmaceutical applications.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block in the multi-step synthesis of novel peptide-based drug candidates.
• Active Pharmaceutical Ingredient (API) Research: Used in preclinical and clinical research as a potential API for targeted therapies.
• Biochemical Research: Employed in academic and industrial laboratories to study peptide-protein interactions, enzyme inhibition, and signal transduction pathways.
• Drug Discovery & Development: A key material in high-throughput screening and structure-activity relationship (SAR) studies to identify new therapeutic leads.
• Reference Standard: Utilized as a high-purity analytical standard for quality control and method development in peptide analysis.

Basic Information

Product Name	C(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm
CAS No.	1647119-71-8
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Cyclo(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm; Argipressin antagonist peptide derivative; CAS 1647119-71-8; Peptide V2 receptor antagonist intermediate; Cyclic peptide research compound; Bua-Cpa-Thi-Val-Asn-Cys-Pro-Agm cyclic; Pharmaceutical peptide 1647119-71-8
EINECS	Contact for details

Quality Control

Our C(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity, essential for sensitive research and development applications. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP (current Good Manufacturing Practice) guidelines where applicable, and our analytical methods, including HPLC and mass spectrometry, are validated to meet rigorous pharmaceutical standards.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label or COA. Due to its hygroscopic (moisture-sensitive) nature, the container must be kept in a dry environment. For long-term storage, consider desiccants or inert atmosphere packaging to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥ 95.0%
Single Impurity (HPLC)	≤ 1.0%
Water Content (KF)	≤ 5.0%
Peptide Content	≥ 80.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.